Evaluating the promise of inclusion of African ancestry populations in genomics

npj Genomic Medicine

Volumn 5, Issue 1, 2020, Pages

  Bentley, Amy R ^a   Callier, Shawneequa L ^a,b   Rotimi, Charles N ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACHIEVEMENT; ADULT; GENOMICS; HUMAN; REVIEW;

EID: 85081158554     PISSN: None     EISSN: 20567944     Source Type: Journal    
DOI: 10.1038/s41525-019-0111-x     Document Type: Review

References (139)

1. Martin, A. R. et al. Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet. 100, 635–649 (2017).
2. Popejoy, A. B. et al. The clinical imperative for inclusivity: race, ethnicity, and ancestry (REA) in genomics. Hum. Mutat. 39, 1713–1720 (2018).
3. Rotimi, C. N. et al. The genomic landscape of African populations in health and disease. Hum. Mol. Genet. 26, R225–R236 (2017).
4. Landry, L. G., Ali, N., Williams, D. R., Rehm, H. L. & Bonham, V. L. Lack of diversity in genomic databases is a barrier to translating precision medicine research into practice. Health Aff. 37, 780–785 (2018).
5. Landry, L. G. & Rehm, H. L. Association of racial/ethnic categories with the ability of genetic tests to detect a cause of cardiomyopathy. JAMA Cardiol. 3, 341–345 (2018).
6. McClellan, J. M., Lehner, T. & King, M.-C. Gene discovery for complex traits: lessons from Africa. Cell 171, 261–264 (2017).
7. Hindorff, L. A. et al. Prioritizing diversity in human genomics research. Nat. Rev. Genet. 19, 175 (2017).
8. Martin, A. R., Teferra, S., Möller, M., Hoal, E. G. & Daly, M. J. The critical needs and challenges for genetic architecture studies in Africa. Curr. Opin. Genet. Dev. 53, 113–120 (2018).
9. Gurdasani, D., Barroso, I., Zeggini, E. & Sandhu, M. S. Genomics of disease risk in globally diverse populations. Nat. Rev. Genet. 20, 520–535 (2019).
10. Morales, J. et al. A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog. Genome Biol. 19, 21 (2018).
11. The Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68 (2015).
12. Murphy, S. A. et al. Effect of the PCSK9 inhibitor evolocumab on total cardiovascular events in patients with cardiovascular disease: a prespecified analysis from the FOURIER trial. JAMA Cardiol. 4, 613–619 (2019).
13. Sabatine, M. S. et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N. Engl. J. Med. 376, 1713–1722 (2017).
14. Chen, G. et al. Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index. Obesity 25, 794–800 (2017).
15. Chen, J. et al. Genome-wide association study of type 2 diabetes in Africa. Diabetologia 62, 1204–1211 (2019).
16. Adeyemo, A. A. et al. ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response. Nat. Commun. 10, 3195 (2019).
17. Tekola-Ayele, F. et al. Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome. Mol. Genet. Metab. 116, 305–313 (2015).
18. Crawford, N. G. et al. Loci associated with skin pigmentation identified in African populations. Science 358, eaan8433 (2017).
19. Levey, D. F. et al. Genetic associations with suicide attempt severity and genetic overlap with major depression. Transl. Psychiatry 9, 22 (2019).
20. Chi, C. et al. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 15, e1007808 (2019).
21. Butali, A. et al. Genomic analyses in African populations identify novel risk loci for cleft palate. Hum. Mol. Genet. 28, 1038–1051 (2018).
22. Sallah, N. et al. Whole-genome association study of antibody response to Epstein-Barr virus in an African population: a pilot. Glob. Health Epidemiol. Genom. 2, e18–e18 (2017).
23. Precision Medicine Initiative (PMI) Working Group. The Precision Medicine Initiative Cohort Program—Building a Research Foundation for 21st Century Medicine (2015).
24. Late, M. Minority, underrepresented groups working to bring diversity to research: all of Us partners engage communities. Nation's Health 48, 17–17 (2019).
25. Manolio, T. A. Using the data we have: improving diversity in genomic research. Am. J. Hum. Genet. 105, 233–236 (2019).
26. Consortium, H. A. Enabling the genomic revolution in Africa. Science 344, 1346 (2014).
27. Chu, K. M., Jayaraman, S., Kyamanywa, P. & Ntakiyiruta, G. Building research capacity in Africa: equity and global health collaborations. PLoS Med. 11, e1001612 (2014).
28. https://h3africa.org/ (2019).
29. Ramsay, M. et al. H3Africa AWI-Gen Collaborative Centre: a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African countries. Glob. Health Epidemiol. Genom. 1, e20–e20 (2016).
30. Ali, S. A. et al. Genomic and environmental risk factors for cardiometabolic diseases in Africa: methods used for Phase 1 of the AWI-Gen population cross-sectional study. Glob. Health Action 11, 1507133–1507133 (2018).
31. Ekoru, K. et al. H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocol. Glob. Health Epidemiol. Genom. 1, e5–e5 (2016).
32. Osafo, C. et al. Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. Kidney Int. 90, 2–5 (2016).
33. Akpalu, A. et al. Phenotyping stroke in sub-Saharan Africa: Stroke Investigative Research and Education Network (SIREN) phenomics protocol. Neuroepidemiology 45, 73–82 (2015).
34. Adebamowo, S. N. et al. Cohort profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME's) Human Papillomavirus (HPV) and Cervical Cancer Study. Int. J. Epidemiol. 46, 1745–1745j (2017).
35. Owolabi, M. O. et al. Data resource profile: Cardiovascular H3Africa Innovation Resource (CHAIR). Int. J. Epidemiol. 48, 366–367g (2018).
36. Stevenson, A. et al. Neuropsychiatric Genetics of African Populations-Psychosis (NeuroGAP-Psychosis): a case-control study protocol and GWAS in Ethiopia, Kenya, South Africa and Uganda. BMJ Open 9, e025469–e025469 (2019).
37. Chatterjee, N., Shi, J. & García-Closas, M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat. Rev. Genet. 17, 392 (2016).
38. Torkamani, A., Wineinger, N. E. & Topol, E. J. The personal and clinical utility of polygenic risk scores. Nat. Rev. Genet. 19, 581–590 (2018).
39. Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219–1224 (2018).
40. Duncan, L. et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat. Commun. 10, 3328 (2019).
41. Spaeth, E., Starlard-Davenport, A. & Allman, R. Bridging the data gap in breast cancer risk assessment to enable widespread clinical implementation across the multiethnic landscape of the US. J. Cancer Treat. Diagn. 2, 1–6 (2018).
42. Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
43. Onengut-Gumuscu, S. et al. Type 1 Diabetes risk in African-ancestry participants and utility of an ancestry-specific Genetic Risk Score. Diab. Care dc181727, 10.2337/dc18-1727 (2019).
44. Mostafavi, H., Harpak, A., Conley, D., Pritchard, J. K. & Przeworski, M. Variable prediction accuracy of polygenic scores within an ancestry group. bioRxiv, 629949. Preprint at https://doi.org/10.1101/629949 (2019).
45. Friedman, P. N. et al. The ACCOuNT Consortium: a model for the discovery, translation and implementation of precision medicine in African Americans. Clin. Transl. Sci. 10.1111/cts.12608 (2018).
46. Levin, A. M. et al. Integrative approach identifies corticosteroid response variant in diverse populations with asthma. J. Allergy Clin. Immunol. 10.1016/j.jaci.2018.09.034 (2018).
47. Mak, A. C. Y. et al. Whole-genome sequencing of pharmacogenetic drug response in racially diverse children with asthma. Am. J. Respir. Crit. Care Med. 197, 1552–1564 (2018).
48. Hernandez-Pacheco, N. et al. Genome-wide association study of inhaled corticosteroid response in admixed children with asthma. Clin. Exp. Allergy 10.1111/cea.13354 (2019).
49. Legge, S. E. et al. A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia. Mol. Psychiatry 10.1038/s41380-018-0335-7 (2019).
50. De, T., Alarcon, C. & Hernandez, W. et al. Association of genetic variants with warfarin-associated bleeding among patients of african descent. JAMA 320, 1670–1677 (2018).
51. Ndadza, A. et al. The genetics of warfarin dose–response variability in Africans: an expert perspective on past, present, and future. OMICS 23, 152–166 (2019).
52. Ramos, E. et al. Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenom. J. 14, 217 (2013).
53. Baker, J. L., Shriner, D., Bentley, A. R. & Rotimi, C. N. Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa. Pharmacogenom. J. 17, 112–120 (2017).
54. Rotimi, C. N. & Jorde, L. B. Ancestry and disease in the age of genomic medicine. N. Engl. J. Med. 363, 1551–1558 (2010).
55. Manrai, A. K. et al. Genetic misdiagnoses and the potential for health disparities. N. Engl. J. Med. 375, 655–665 (2016).
56. Freedman, B. I., Limou, S., Ma, L. & Kopp, J. B. APOL1-associated nephropathy: a key contributor to racial disparities in CKD. Am. J. Kidney Dis. 72, S8–S16 (2018).
57. Reeves-Daniel, A. M. et al. The APOL1 gene and allograft survival after kidney transplantation. Am. J. Transplant. 11, 1025–1030 (2011).
58. Freedman, B. I. et al. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am. J. Transplant. 15, 1615–1622 (2015).
59. Doshi, M. D. et al. APOL1 Genotype and renal function of Black living donors. J. Am. Soc. Nephrol. 29, 1309–1316 (2018).
60. Wheeler, E. et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 14, e1002383 (2017).
61. Hivert, M.-F. et al. Genetic ancestry markers and difference in A1c between African-American and White in the Diabetes Prevention Program. J. Clin. Endocrinol. Metab. jc.2018-01416-jc.02018-01416, 10.1210/jc.2018-01416 (2018).
62. Yuan, J. et al. Integrated analysis of genetic ancestry and genomic alterations across cancers. Cancer Cell 34, 549–560.e549 (2018).
63. Chang, C.-S., Kitamura, E., Johnson, J., Bollag, R. & Hawthorn, L. Genomic analysis of racial differences in triple negative breast cancer. Genomics. 10.1016/j.ygeno.2018.10.010 (2018).
64. Lachance, J. et al. Genetic hitchhiking and population bottlenecks contribute to prostate cancer disparities in men of African descent. Cancer Res. 78, 2432 (2018).
65. Raffield, L. M. et al. D-Dimer in African Americans: whole genome sequence analysis and relationship to cardiovascular disease risk in the Jackson Heart Study. Arterioscler. Thromb. Vasc. Biol. 37, 2220–2227 (2017).
66. Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399 (2009).
67. Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798 (2009).
68. Vutien, P., Hoang, J., Brooks, L. Jr., Nguyen, N. H. & Nguyen, M. H. Racial disparities in treatment rates for chronic Hepatitis C: analysis of a population-based cohort of 73,665 patients in the United States. Medicine 95, e3719–e3719 (2016).
69. Bien, S. A. et al. The future of genomic studies must be globally representative: perspectives from PAGE. Annu. Rev. Genom. Hum. Genet. 20, null (2019).
70. Data Sheet, Axiom Genome-Wide Pan-African Array Set. http://tools.thermofisher.com/content/sfs/brochures/axiom_panafr_arrayplate_datasheet.pdf.
71. Huang, L. et al. Genotype-imputation accuracy across worldwide human populations. Am. J. Hum. Genet. 84, 235–250 (2009).
72. Haplotype Reference Consortium et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279 (2016).
73. Mathias, R. A. et al. A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome. Nat. Commun. 7, 12522 (2016).
74. Vergara, C. et al. Genotype imputation performance of three reference panels using African ancestry individuals. Hum. Genet. 137, 281–292 (2018).
75. Schurz, H. et al. Evaluating the accuracy of imputation methods in a five-way admixed population. Front. Genet. 10, 10.3389/fgene.2019.00034 (2019).
76. Mulder, N. et al. H3Africa: current perspectives. Pharmacogenom. Personalized Med. 11, 59–66 (2018).
77. Wetterstrand, K. A. DNA Sequencing Costs: Data. https://www.genome.gov/about-genomics/fact-sheets/DNA-Sequencing-Costs-Data (2019).
78. National Science Foundation. Women, Minorities, and Persons with Disabilities in Science and Engineering: 2019 (National Center for Science and Engineering Statistics, Alexandria, VA, 2019).
79. Ginther, D. K. et al. Race, ethnicity, and NIH research awards. Science 333, 1015 (2011).
80. Hoppe, T. A. et al. Topic choice contributes to the lower rate of NIH awards to African-American/black scientists. Sci. Adv. 5, eaaw7238 (2019).
81. Quick Facts: United States. https://www.census.gov/quickfacts/fact/table/US/PST045218.
82. Uthman, O. A. et al. Increasing the value of health research in the WHO African Region beyond 2015—reflecting on the past, celebrating the present and building the future: a bibliometric analysis. BMJ Open 5, e006340–e006340 (2015).
83. Bentley, A. R., Callier, S. & Rotimi, C. The emergence of genomic research in Africa and new frameworks for equity in biomedical research. Ethn. Dis. 29, 179–186 (2019).
84. van der Merwe, C. et al. Advancing neuropsychiatric genetics training and collaboration in Africa. Lancet Glob. Health 6, e246–e247 (2018).
85. Mulder, N. J. H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa. Genome Res. 26, 271–277 (2016).
86. Mulder, N. Development to enable precision medicine in Africa. Personalized Med. 14, 467–470 (2017).
87. Ofon, E. et al. A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations. PLoS Neglect. Trop. Dis. 11, e0005979 (2017).
88. Kaboré, J. W. et al. Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea. PLoS Negl. Trop. Dis. 11, e0005833–e0005833 (2017).
89. Ahouty, B. et al. Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d’Ivoire. PLoS Negl. Trop. Dis. 11, e0005992–e0005992 (2017).
90. Kimuda, M. P. et al. No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations. PLoS Negl. Trop. Dis. 12, e0006300–e0006300 (2018).
91. Cooper, A. et al. APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. eLife 6, e25461 (2017).
92. Ilboudo, H. et al. Introducing the TrypanoGEN biobank: a valuable resource for the elimination of human African trypanosomiasis. PLoS Negl. Trop, Dis. 11, e0005438–e0005438 (2017).
93. Dennis-Antwi, J. A. et al. Relation between religious perspectives and views on sickle cell disease research and associated public health interventions in Ghana. J. Genet. Couns. 10.1007/s10897-018-0296-7 (2018).
94. Landouré, G. et al. Neurological complications in subjects with sickle cell disease or trait: genetic results from Mali. Glob. Heart 12, 77–80 (2017).
95. Wonkam, A. et al. Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon. Br. J. Haematol. 180, 134–146 (2018).
96. Carter, A., Liddle, J., Hall, W. & Chenery, H. Mobile phones in research and treatment: ethical guidelines and future directions. JMIR Mhealth Uhealth 3, e95–e95 (2015).
97. Adebamowo, S. N. et al. Implementation of genomics research in Africa: challenges and recommendations. Glob. Health Action 11, 1419033 (2018).
98. Tsosie, K. S., Yracheta, J. M. & Dickenson, D. Overvaluing individual consent ignores risks to tribal participants. Nat. Rev. Genet. 20, 497–498 (2019).
99. de Vries, J. & Munung, N. S. Ethical considerations in genomic research in South Africa %J SAMJ. South Afr. Med. J. 109, 375–377 (2019).
100. Pratt, B. & de Vries, J. Community engagement in global health research that advances health equity. Bioethics 32, 454–463, 10.1111/bioe.12465 (2018).
101. Yozwiak, N. L. et al. Roots, not parachutes: research collaborations combat outbreaks. Cell 166, 5–8 (2016).
102. de Vries, J. et al. The H3Africa policy framework: negotiating fairness in genomics. Trends Genet. 31, 117–119 (2015).
103. Ramsay, M. & Sankoh, O. African partnerships through the H3Africa Consortium bring a genomic dimension to longitudinal population studies on the continent. Int. J. Epidemiol. 45, 305–308 (2015).
104. High-Level Principles on Ethics, Governance and Resource Sharing. https://h3africa.org/index.php/about/ethics-and-governance/.
105. Yakubu, A. et al. Model framework for governance of genomic research and biobanking in Africa? a content description [version 1; referees: 3 approved]. AAS Open Res. 1, 10.12688/aasopenres.12844.1 (2018).
106. NHLBI Trans-Omics for Precision Medicine: About TOPMed. https://www.nhlbiwgs.org/#Study%20Characteristics.
107. Wojcik, G. L. et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature 570, 514–518 (2019).
108. Giri, A. et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat. Genet. 51, 51–62 (2019).
109. Sung, Y. J. et al. A large-scale multi-ancestry genome-wide study accounting for smoking behavior identifies multiple significant loci for blood pressure. Am. J. Hum. Genet. 102, 375–400 (2018).
110. Daya, M. et al. Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations. Nat. Commun. 10, 880 (2019).
111. Natarajan, P. et al. Deep-coverage whole genome sequences and blood lipids among 16,324 individuals. Nat. Commun. 9, 3391 (2018).
112. Zekavat, S. M. et al. Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. Nat. Commun. 9, 2606 (2018).
113. Prokopenko, D. et al. Whole-genome sequencing in severe chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 59, 614–622 (2018).
114. Wheeler, M. M. et al. Genomic characterization of the RH locus detects complex and novel structural variation in multi-ethnic cohorts. Genet. Med. 21, 477–486 (2018).
115. Gong, J. et al. Trans-ethnic analysis of metabochip data identifies two new loci associated with BMI. Int. J. Obes. 42, 384 (2017).
116. Fernández-Rhodes, L. et al. Trans-ethnic fine-mapping of genetic loci for body mass index in the diverse ancestral populations of the Population Architecture using Genomics and Epidemiology (PAGE) Study reveals evidence for multiple signals at established loci. Hum. Genet. 136, 771–800 (2017).
117. Yoneyama, S. et al. Generalization and fine mapping of European ancestry-based central adiposity variants in African ancestry populations. Int. J. Obes. 41, 324 (2016).
118. Zubair, N. et al. Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci. Hum. Mol. Genet. 25, 5500–5512 (2016).
119. Bien, S. A. et al. Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium. Diabetologia 60, 2384–2398 (2017).
120. Avery, C. L. et al. Fine mapping of QT interval regions in global populations refines previously identified QT interval loci and identifies signals unique to African and Hispanic descent populations. Heart Rhythm 14, 572–580 (2017).
121. Fernández-Rhodes, L. et al. The genetic underpinnings of variation in ages at menarche and natural menopause among women from the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) Study: a trans-ethnic meta-analysis. PLoS ONE 13, e0200486 (2018).
122. Kocarnik, J. M. et al. Discovery, fine-mapping, and conditional analyses of genetic variants associated with C-reactive protein in multiethnic populations using the Metabochip in the Population Architecture using Genomics and Epidemiology (PAGE) study. Hum. Mol. Genet. 27, 2940–2953 (2018).
123. Franceschini, N. et al. Variant discovery and fine mapping of genetic loci associated with blood pressure traits in hispanics and African Americans. PLoS ONE 11, e0164132–e0164132 (2016).
124. Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet. 50, 1514–1523 (2018).
125. Rao, D. C. et al. Multiancestry study of gene–lifestyle interactions for cardiovascular traits in 610 475 individuals from 124 cohorts: design and rationale. Circ. Cardiovasc. Genet. 10, e001649 (2017).
126. Feitosa, M. F. et al. Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570 K individuals across multiple ancestries. PLOS ONE 13, e0198166 (2018).
127. Sung, Y. J. et al. A multi-ancestry genome-wide study incorporating gene-smoking interactions identifies multiple new loci for pulse pressure and mean arterial pressure. Hum. Mol. Genet. Preprint at 10.1093/hmg/ddz070 (2019). [Epub ahead of print].
128. Bentley, A. R. et al. Multi-ancestry genome-wide gene–smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids. Nat. Genet. 51, 636–648 (2019).
129. de Vries, P. S. et al. Multi-ancestry genome-wide association study of lipid levels incorporating gene–alcohol interactions. Am. J. Epidemiol. 188, 1033–1054 (2019).
130. Noordam, R. et al. Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration. Nat. Commun. 10, 5121 (2019).
131. Johnston, H. R. et al. Identifying tagging SNPs for African specific genetic variation from the African Diaspora Genome. Sci. Rep. 7, 46398–46398 (2017).
132. Kessler, M. D. et al. Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry. Nat. Commun. 7, 12521 (2016).
133. Daya, M. et al. Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations. Nat. Commun. 10, 880 (2019).
134. Ndila, C. M. et al. Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study. Lancet Haematol. 5, e333–e345 (2018).
135. Opi, D. H. et al. Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+ thalassaemia. eLife 7, e31579 (2018).
136. Leffler, E. M. et al. Resistance to malaria through structural variation of red blood cell invasion receptors. Science 356, eaam6393 (2017).
137. Clarke, G. M. et al. Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia. eLife 6, e15085 (2017).
138. Busby, G. B. J. et al. Admixture into and within sub-Saharan Africa. eLife 5, e15266 (2016).
139. Baker, J. L., Rotimi, C. N. & Shriner, D. Human ancestry correlates with language and reveals that race is not an objective genomic classifier. Sci. Rep. 7, 1572 (2017).